Search results - 7 results
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Volume 125, Issue 2 (2019) Keywords: Adult Case-Control Studies Female Follow-Up Studies Human papillomavirus 16 Human papillomavirus 18 Humans middle aged Papillomaviridae Papillomavirus Infections Risk ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
Issue 1 (2019) Keywords: cancer Determining factors Life course Return-to-work Abstract: Background: The improvements in cancer control led to an increase in the number of cancer survivors, notably, in ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
future decision-making in cervical cancer control. Health Topics: Quality of healthcare Cancer Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Kanker Service: Centre du cancer ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Volume 363 (2018) Keywords: Colposcopy Early Detection of Cancer Female Humans incidence Intention to Treat Analysis Mass Screening Papillomaviridae Papillomavirus Infections Randomized Controlled Trials ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
the nonavalent vaccine were excluded since women in the control group received the quadrivalent vaccine. Main efficacy outcomes were: histologically confirmed cervical precancer lesions distinguishing ...
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Abstract: BACKGROUND: Well-organised quality-controlled screening can substantially reduce the burden of cervical cancer (CC). European guidelines (EuG) for quality assurance in CC screening provide guidance ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
with an internal control probe. Here, we present an analysis of the clinical performance of the LMNX using a sample panel and infrastructure provided by the international VALGENT (Validation of ...